Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

ClinicalTrials.gov ID: NCT07845500

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07845500. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 7:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 3 STUDY TO EVALUATE THE SWITCH TO MONTHLY BEROBENATIDE FOR MAINTAINING WEIGHT IN ADULTS WHO ARE ON WEEKLY SEMAGLUTIDE OR TIRZEPATIDE (VESPER-SWITCH)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to learn about the safety and effectiveness of berobenatide in adults with overweight or obesity who have already lost weight while taking semaglutide or tirzepatide. The study does not include people with diabetes. Participants will be in the study for about 11 months.

Study identification

NCT ID
NCT07845500
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
660 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2026 (Actual)
Primary completion
Feb 16, 2028 (Estimated)
Completion
Feb 16, 2028 (Estimated)
Last update posted
Nov 5, 2026

2026 – 2028

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 Recruiting
San Fernando Valley Health Institute Canoga Park California 91304 Recruiting
Velocity Clinical Research - Los Angeles Los Angeles California 90017 Recruiting
Headlands Research Sacramento Sacramento California 95821 Not yet recruiting
Southern California Clinical Research Santa Ana California 92701 Recruiting
Diablo Clinical Research, LLC dba Flourish Research Walnut Creek California 94598 Recruiting
Southern California Retina Specialists West Hills California 91307 Recruiting
Westside Center for Clinical Research Jacksonville Florida 32205 Not yet recruiting
Jacksonville Center for Clinical Research Jacksonville Florida 32216 Recruiting
Suncoast Clinical Research New Port Richey Florida 34652 Recruiting
Oviedo Medical Research Oviedo Florida 32765 Recruiting
Center for Diabetes, Obesity and Metabolism Inc Pembroke Pines Florida 33024 Not yet recruiting
MediSphere Medical Research Center, LLC Evansville Indiana 47714 Recruiting
Monroe Biomedical Research Louisville Kentucky 40213 Recruiting
Aa Mrc Llc Flint Michigan 48504 Recruiting
SKY Integrative Medical Center/SKYCRNG Ridgeland Mississippi 39157 Not yet recruiting
Clinical Research Professionals Chesterfield Missouri 63005 Recruiting
Mercury Street Medical Group, PLLC Butte Montana 59701 Recruiting
Medication Management, LLC Greensboro North Carolina 27401 Recruiting
Monroe Biomedical Research Monroe North Carolina 28112 Not yet recruiting
Accellacare - Wilmington Wilmington North Carolina 28401 Recruiting
Velocity Clinical Research, Mt. Auburn Cincinnati Ohio 45219 Recruiting
Tribe Clinical Research, LLC Greenville South Carolina 29607 Recruiting
York Clinical Research, LLC Norfolk Virginia 23504 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07845500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 5, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.